Allison C. Hoffman Sells 4,585 Shares of Phreesia, Inc. (NYSE:PHR) Stock

Phreesia, Inc. (NYSE:PHR) General Counsel Allison C. Hoffman sold 4,585 shares of the firm’s stock in a transaction on Wednesday, January 15th. The shares were sold at an average price of $26.90, for a total value of $123,336.50. Following the transaction, the general counsel now directly owns 154,552 shares in the company, valued at $4,157,448.80. This trade represents a 2.88 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this link.

Phreesia Stock Up 1.6 %

Shares of NYSE:PHR opened at $27.24 on Friday. The firm has a 50 day simple moving average of $23.54 and a 200 day simple moving average of $22.81. Phreesia, Inc. has a 52 week low of $17.07 and a 52 week high of $29.16. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.74 and a current ratio of 1.74. The company has a market cap of $1.58 billion, a PE ratio of -18.53 and a beta of 0.94.

Phreesia (NYSE:PHR) last posted its quarterly earnings results on Monday, December 9th. The company reported ($0.25) earnings per share for the quarter, beating the consensus estimate of ($0.29) by $0.04. Phreesia had a negative return on equity of 32.78% and a negative net margin of 20.43%. The firm had revenue of $106.80 million for the quarter, compared to analyst estimates of $106.33 million. During the same period in the previous year, the firm earned ($0.58) earnings per share. Phreesia’s quarterly revenue was up 16.6% on a year-over-year basis. As a group, research analysts expect that Phreesia, Inc. will post -1.1 earnings per share for the current year.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Champlain Investment Partners LLC boosted its stake in shares of Phreesia by 4.1% during the 3rd quarter. Champlain Investment Partners LLC now owns 2,503,837 shares of the company’s stock valued at $57,062,000 after buying an additional 97,847 shares during the period. Franklin Resources Inc. grew its stake in Phreesia by 3.0% in the third quarter. Franklin Resources Inc. now owns 1,497,631 shares of the company’s stock valued at $31,495,000 after purchasing an additional 42,973 shares in the last quarter. State Street Corp increased its position in Phreesia by 7.1% in the 3rd quarter. State Street Corp now owns 1,327,586 shares of the company’s stock worth $30,256,000 after purchasing an additional 88,517 shares during the last quarter. Geode Capital Management LLC lifted its holdings in shares of Phreesia by 4.7% during the 3rd quarter. Geode Capital Management LLC now owns 1,245,797 shares of the company’s stock valued at $28,397,000 after buying an additional 55,934 shares during the last quarter. Finally, TimesSquare Capital Management LLC grew its stake in shares of Phreesia by 2.3% in the 3rd quarter. TimesSquare Capital Management LLC now owns 868,409 shares of the company’s stock valued at $19,791,000 after buying an additional 19,395 shares in the last quarter. 92.10% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several equities analysts have commented on the stock. Citigroup raised their target price on shares of Phreesia from $31.00 to $35.00 and gave the company a “buy” rating in a research note on Friday, January 10th. KeyCorp boosted their target price on Phreesia from $28.00 to $30.00 and gave the stock an “overweight” rating in a report on Wednesday, January 8th. Robert W. Baird lowered their price target on Phreesia from $34.00 to $30.00 and set an “outperform” rating on the stock in a research report on Wednesday, December 11th. Needham & Company LLC restated a “buy” rating and issued a $29.00 price objective on shares of Phreesia in a report on Friday, January 10th. Finally, Royal Bank of Canada upgraded shares of Phreesia from a “sector perform” rating to an “outperform” rating and boosted their price target for the stock from $24.00 to $32.00 in a research report on Wednesday, January 8th. Twelve analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the stock currently has an average rating of “Buy” and an average price target of $31.00.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.